ABBV vs FCX · P/E 81, rev $16.99B vs P/E 38, rev $13.26B
AbbVie Inc (ABBV) versus Freeport-McMoran Copper & Gold Inc (FCX) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported FCX revenue for 2026-06-30 was $13.26B. Net income was $1.86B. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Not investment advice. Open the ABBV and FCX stock pages for the full models.
Not investment advice.